Ahmed Abuzaid is a Cardiology physician affiliated with University of Alaska Anchorage. OpenAlex indexes 56 publications with 713 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3841 Piper Street Suite T100
Anchorage, AK 995084674
Telephone
907-561-3211Provider last certified this registry record 14 Jan 2026.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20255 payments$11,659openpaymentsdata.cms.gov ↗
- E.R. Squibb & Sons, L.L.C.Program year202517 payments
- BridgeBio Pharma, Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
85.5%Adenosine Receptor Agonist30.1%Adenosine60%Regadenoson40%Part B, office-administered≥101 patientsBeta blocker15.1%Metoprolol Succinate68%Carvedilol16%Metoprolol Tartrate9%Bisoprolol Fumarate7%Part D<11 patients+ 15 more classes in this area
Blood & clotting
10.1%Factor Xa inhibitor6.9%Eliquis79%Xarelto21%Part D≥48 patientsP2Y12 inhibitor2.1%Clopidogrel100%Part D≥22 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.5%Potassium supplement1.6%Potassium Chloride100%Part D≥20 patientsProton pump inhibitor1.3%Pantoprazole Sodium73%Esomeprazole Magnesium27%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Bridging the Gap in AL and ATTR Cardiac Amyloidosis: Integrating Histopathology, Biomarkers, and Multimodal Imaging for Subtype-Specific Diagnosis
Reviews in Cardiovascular Medicine
2026 - ACR Appropriateness Criteria® Suspected and Known Renal or Splanchnic Artery Aneurysm
Journal of the American College of Radiology
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”